Investor profile
Newton Biocapital has backed 3 European tech companies across 3 funding rounds between 2017 and 2023, joining rounds totalling €167M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Acticor biotech | France | 1 | €153M |
| Synergia | Belgium | 1 | €8.1M |
| DeuterOncology | Belgium | 1 | €5.7M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Acticor biotech | Series B | €153M | 2018-11 |
| Synergia | Series A | €8.1M | 2018-01 |
| DeuterOncology | Series A | €5.7M | 2023-01 |
